EQUILLIUM, INC. Proceeds from Issuance of Private Placement
EQUILLIUM, INC. (EQ) reported Proceeds from Issuance of Private Placement of $34.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-13
- EQUILLIUM, INC. proceeds from issuance of private placement for the quarter ending 2026-06-30 was -$100.00K.
- EQUILLIUM, INC. proceeds from issuance of private placement for the quarter ending 2026-03-31 was $34.90M, a 65745.28% increase year-over-year.
- EQUILLIUM, INC. proceeds from issuance of private placement for the quarter ending 2025-12-31 was -$184.00K.
- EQUILLIUM, INC. proceeds from issuance of private placement for the quarter ending 2025-03-31 was $53.00K.
- EQUILLIUM, INC. proceeds from issuance of private placement for fiscal 2025 was $27.91M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $34.80M 10-Q · filed 2026-08-13 | $34.61M derived: sum of 3 quarters · filed 2026-08-13 | |
| 2026-03-31 | $34.90M 10-Q · filed 2026-05-13 | $34.71M derived: sum of 2 quarters · filed 2026-05-13 | ||
| 2025-12-31 | -$184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $27.91M 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $28.09M 10-Q · filed 2025-11-13 | |||
| 2025-03-31 | $53.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |